FDA: Ameridose issues voluntary recall of all products

FDA: ameridose issues voluntary recall of all products
Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

As yet, no patients have been reported to have experienced infections or other complications in association with Ameridose products. The recall was prompted out of concern that sterility assurance for products made and distributed by the facility is lacking. This concern was raised by the preliminary findings of an FDA investigation of the manufacturer's facility as part of an ongoing investigation into the fungal linked with Ameridose's sister company, the Compounding Center of Framingham, Mass.

Acknowledging that the recall stems from an abundance of caution rather than an actual adverse event, the FDA is not at this time recommending that physicians follow up with patients who have received Ameridose products, only that they stop using these products and return them. Hospitals, clinics, and other customers with Ameridose products can call the company at 888-820-0622 for guidance on returning the products.

"The FDA's top priority is to ensure that drugs are safe for the American public," Margaret A. Hamburg, M.D., FDA Commissioner, said in a statement.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

2nd firm agrees to temporary shutdown in outbreak

Oct 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Suit: Firm provided tainted meds in 2002, man died

Oct 11, 2012

The compounding pharmacy suspected in a deadly meningitis outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004, while a pharmaceutical firm with common owners was ...

Tainted drug death toll rises to 14 in US

Oct 11, 2012

The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

US pharmacy linked to outbreak issues wide recall

Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Some Total Body-brand products recalled

Mar 31, 2008

The U.S. Food and Drug Administration announced the recall of certain flavors of Total Body Formula and Total Body Mega Formula due to safety issues.

Recommended for you

Health care M&A leads global deal surge

11 hours ago

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.